Eventide Asset Management, LLC Apellis Pharmaceuticals, Inc. Transaction History

Eventide Asset Management, LLC

  • $5.67 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$37.14 - $64.82 $7.79 Million - $13.6 Million
209,794 New
209,794 $12.6 Million
Q2 2023

Aug 15, 2023
SELL
$76.68 - $93.31 $7.5 Million - $9.13 Million
-97,859 Reduced 19.77%
397,141 $36.2 Million
Q1 2023

May 15, 2023
BUY
$46.59 - $66.96 $7.25 Million - $10.4 Million
155,645 Added 45.86%
495,000 $32.7 Million
Q3 2022

Nov 14, 2022
BUY
$44.76 - $69.66 $15.2 Million - $23.6 Million
339,355 New
339,355 $23.2 Million

Others Institutions Holding APLS

# of Institutions
310
Shares Held
113M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.29B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email